Retinitis pigmentosa 23 is a rare inherited eye condition that slowly damages the light-sensing cells in the retina. Early symptoms of retinitis pigmentosa 23 often include trouble seeing in dim light and gradual loss of side vision. It can begin in childhood or adulthood, and not everyone will have the same experience. Retinitis pigmentosa 23 usually lasts lifelong and may lead to severe visual impairment over time, but it does not usually affect life expectancy. Treatment focuses on monitoring, low-vision support, and managing complications such as cataracts or swelling in the retina.
How many people live with Retinitis pigmentosa 23?
Retinitis pigmentosa as a whole is estimated to affect about 1.5 million people worldwide and about 100,000 people in the United States (Foundation Fighting Blindness, 2024). Retinitis pigmentosa 23 is one very rare inherited type of this condition, but separate worldwide and U.S. counts for this exact type are not consistently reported by a single reliable source.
Overview
Retinitis pigmentosa 23Symptoms
Retinitis pigmentosa 23 usually causes slowly worsening night blindness and trouble seeing to the sides. Many people first notice bumping into things in dim light or missing steps. Early symptoms of Retinitis pigmentosa 23 can start in childhood or adulthood.
Outlook and prognosis
Many people with retinitis pigmentosa 23 keep central vision for years, but night vision and side vision often worsen over time. The pace varies, and regular eye care, low-vision support, and genetic counseling can help with daily life and planning.
Causes and risk factors
Retinitis pigmentosa 23 is caused by a change in the PRPF8 gene, usually inherited in an autosomal dominant pattern, though it can start new in a family. Lifestyle and environment do not cause it, but they may affect coping and eye health.
Genetic influences
Genetics are central to retinitis pigmentosa 23. It is caused by a change in a specific gene and is usually inherited, so family history and genetic testing can be very important.
Diagnosis
Doctors diagnose Retinitis pigmentosa 23 from eye symptoms, a retinal exam, and imaging tests. Vision tests and electroretinography often support the diagnosis. Genetic tests can confirm the genetic diagnosis of Retinitis pigmentosa 23.
Treatment and drugs
Treatment for Retinitis pigmentosa 23 focuses on protecting vision and making daily life easier. Care may include regular eye monitoring, low-vision aids, orientation training, and treatment for complications such as cataracts or swelling in the retina.
Symptoms
Retinitis pigmentosa 23 often first affects how well you see in dim light and at the edges of your vision. Common early features of retinitis pigmentosa 23 include trouble getting around at night, slower adjustment between light and dark places, and gradually narrowing side vision. Features vary from person to person and can change over time.
Seeing in dim rooms, parking lots, or outside after sunset may become difficult. Many people with retinitis pigmentosa 23 need brighter light and more time to spot steps, curbs, or objects in low light.
Vision at the edges may slowly narrow, sometimes leading to a tunnel vision effect. This can make it easier to miss people, cars, or obstacles coming from the side.
Moving from bright sunlight into a darker hallway may leave vision blurry or patchy for longer than expected. The same thing can happen when lights are turned down in a restaurant or theater.
Bright sun, headlights, or shiny floors may wash out details and make contrast harder to see. For many living with retinitis pigmentosa 23, stairs, doorways, and uneven ground stand out less clearly in this kind of light.
How people usually first notice Retinitis pigmentosa 23?
How retinitis pigmentosa 23 is first noticed often starts quietly: many people first realize they do not see well in dim light, take longer to adjust when moving from bright places into darkness, or feel unusually unsure walking at night. As the condition progresses, the first signs of retinitis pigmentosa 23 can include bumping into objects off to the side, trouble seeing steps or curbs, and a gradual narrowing of side vision, sometimes described as tunnel vision. In some families it is picked up earlier because relatives have had similar vision problems, while in others it is first recognized during an eye exam after these early changes begin.
Types of Retinitis pigmentosa 23
Retinitis pigmentosa 23 is already a specific genetic form of retinitis pigmentosa, so experts do not usually divide it into further well-established clinical variants. Symptoms can still vary from one person to another, including differences in when night vision problems begin, how quickly side vision changes, and how much central vision is affected over time. In other words, people may experience different patterns of the condition, but no distinct types of retinitis pigmentosa 23 are widely recognized.
Can I slow down the onset of symptoms?
At this time, there is no good evidence that lifestyle changes or medicines can meaningfully delay the start of symptoms in retinitis pigmentosa 23, a genetic eye condition. Healthy habits such as not smoking, protecting your eyes from very bright light, and managing problems like high blood pressure or diabetes may support overall eye health, but they have not been proven to prevent this condition or postpone when it begins; research on gene-based treatments is still ongoing. Even without a proven way to slow onset, regular follow-up with an eye doctor can help you plan ahead and stay informed about new options as they emerge.
What genetics can tell you about symptoms
Genetics can sometimes help explain why retinitis pigmentosa 23 looks different from one person to another, including which vision symptoms show up first, how quickly they worsen, and the age when problems begin. In general, changes in the same gene can still affect people differently, so genetic results may give clues about the pattern of disease but usually cannot predict the exact course for one individual. For many living with this condition, genetics is most useful for confirming the diagnosis, estimating likely progression in a broad sense, and helping guide family counseling and access to research or treatment trials.
Causes and risk factors
The genetic cause of retinitis pigmentosa 23 is usually a harmful change in the OFD1 gene, which helps retinal cells stay healthy. Family history is the main risk factor because this gene change can be passed down, often in an X-linked way. Many living with retinitis pigmentosa 23 are more severely affected if they are male, while females who carry the change may have milder symptoms or none. Lifestyle and environmental factors do not cause this condition, but smoking, diabetes, and other eye problems can make vision changes harder to manage. Risk can vary widely from person to person, and genetic testing can help clarify personal risk.
What are the most common causes or risk factors?
Retinitis pigmentosa 23 is usually caused by an inherited gene change that affects the retina, the light-sensing layer at the back of the eye. The main risk factor is family history, especially having a parent or close relative with this kind of inherited vision loss, although a new gene change can sometimes happen in someone with no known family history. There are no well-established lifestyle or environmental causes for this subtype.
Environmental and biological risk factors
When people ask about risk factors for retinitis pigmentosa 23, the key point is that clear environmental or non-genetic biological risks have not been firmly established. Researchers are still exploring how outside influences interact with our inner biology, but this specific form is generally tied to a body-based cause present from conception rather than everyday exposures. That means doctors do not usually identify pollution, stress, or routine pregnancy-related factors as proven causes of retinitis pigmentosa 23.
No environmental exposure has been clearly shown to cause retinitis pigmentosa 23. At this time, outside factors such as pollution or chemical exposures have not been confirmed as established triggers for this specific subtype.
No separate non-genetic body-based risk factor has been firmly linked to retinitis pigmentosa 23. Factors sometimes discussed for some congenital conditions, such as parental age or birth complications, are not established causes of this subtype.
Genetic risk factors
In retinitis pigmentosa 23, the main genetic cause is a harmful change in OFD1, a gene on the X chromosome that helps cells in the retina work normally. Because this gene is on the X chromosome, the inherited risk pattern is different from many other forms of retinitis pigmentosa and often affects males more clearly than females. Some risk factors are inherited through our genes. In some cases, the change is new in the family rather than passed down from a parent.
OFD1 gene: Retinitis pigmentosa 23 is linked to disease-causing changes in OFD1. When this gene does not work as it should, light-sensing cells in the retina gradually become damaged.
X-linked pattern: OFD1 sits on the X chromosome, so this condition usually follows an X-linked inheritance pattern. Males often have a higher chance of developing symptoms because they have only one X chromosome.
Family history: A family history of retinitis pigmentosa 23 or related vision loss on the mother’s side can raise inherited risk. If several male relatives had night blindness or narrowing side vision, that pattern can be an important clue.
Female carriers: Females with one altered OFD1 copy may have no symptoms, mild retinal changes, or sometimes clearer vision problems. Risk is not destiny—it varies widely between individuals. This partly depends on which X chromosome is active in more retinal cells.
New variant: Sometimes the genetic change appears for the first time in someone with no known family history. This is called a new, or de novo, variant and can still lead to retinitis pigmentosa 23.
Variant differences: Not all OFD1 changes affect the retina in the same way. This helps explain why early symptoms of retinitis pigmentosa 23 and the pace of vision loss can differ even within the same family.
Lifestyle risk factors
Retinitis pigmentosa 23 is an inherited retinal disorder, so lifestyle habits do not cause it. Still, how lifestyle affects retinitis pigmentosa 23 can matter for day-to-day vision, safety, eye strain, and the risk of avoidable complications. The most useful focus is on habits that support remaining vision and overall eye health.
Smoking does not cause retinitis pigmentosa 23, but it can increase oxidative stress that may further burden retinal cells. Avoiding tobacco may help protect overall eye and blood vessel health as vision changes over time.
A balanced diet with regular meals supports general retinal and nerve health, while poor nutrition can worsen fatigue and make visual function feel less reliable. For lifestyle risk factors for retinitis pigmentosa 23, unhealthy eating matters mainly because it may add avoidable eye and cardiovascular stress rather than trigger the disease itself.
Regular physical activity does not reverse the genetic condition, but it can support circulation, balance, mobility, and independence as peripheral vision narrows. Inactivity and deconditioning may make it harder to adapt to low-light vision problems and increase fall risk.
Excessive bright light and glare can worsen discomfort and reduce useful vision for some people with retinitis pigmentosa 23. Using sunglasses, glare control, and sensible lighting may improve function and reduce visual strain outdoors or in harsh indoor light.
Risk prevention
Retinitis pigmentosa 23 is an inherited eye condition, so most people cannot prevent the disease itself from developing. Prevention usually means lowering the chance of faster vision loss, avoiding extra strain on the eyes, and catching treatable problems early. Different people need different prevention strategies—there’s no single formula.
If retinitis pigmentosa 23 runs in your family, genetic counseling can help you understand inheritance and family planning options. It can also clarify who in the family may benefit from testing or eye exams.
Ongoing care with an eye specialist can help spot cataracts, swelling in the center of the retina, or other problems that may be treatable. Regular check-ups also help track changes such as the early symptoms of retinitis pigmentosa 23 over time.
Wearing sunglasses that block UV light and using protective eyewear during sports or risky work may help reduce added eye injury. For many living with retinitis pigmentosa 23, avoiding preventable damage is an important part of protecting the vision they have.
Smoking can add stress to eye tissues and blood vessels, which is not helpful for people with retinal disease. If you smoke, quitting may support overall eye and heart health.
Can you prevent Retinitis pigmentosa 23?
No, retinitis pigmentosa 23 cannot usually be prevented, because it is caused by a change in a gene that is passed down in families. If this condition runs in your family, genetic counseling can help you understand the chances of it affecting you or your children, but it cannot stop the condition from happening. Regular eye checkups and healthy habits like not smoking may help protect overall eye health, but they are not proven to prevent retinitis pigmentosa 23.
Transmission
Retinitis pigmentosa 23 is not infectious, so it cannot be passed from one person to another through touch, coughing, sex, blood, food, or everyday contact. Instead, the genetic transmission of retinitis pigmentosa 23 usually happens within families.
This form of retinitis pigmentosa is most often inherited in an autosomal dominant pattern, which means a parent with the gene change can pass it to each child with a 1 in 2, or 50%, chance in every pregnancy. Sometimes retinitis pigmentosa 23 can start because of a new gene change in someone with no family history, and that person can then pass it on to their children.
When to test your genes
Consider genetic testing if you or close relatives have night blindness, shrinking side vision, or a family history of inherited retinal disease. In retinitis pigmentosa 23, testing can confirm the gene cause, sharpen prognosis, guide eligibility for gene-specific studies, and help relatives understand their own risk.
Diagnosis
Retinitis pigmentosa 23 is usually diagnosed when ongoing night vision problems, trouble seeing off to the sides, or a family history point to an inherited eye condition. Doctors confirm it by combining a detailed eye exam with tests that show how the retina is working and, when needed, genetic testing. Getting a diagnosis is often a turning point toward answers and support.
Doctors ask about night blindness, side vision loss, and when symptoms began. A detailed family and health history can help show whether retinitis pigmentosa 23 may run in the family.
An eye specialist looks at the back of the eye after widening the pupils with drops. They may see pigment changes, narrowing of blood vessels, and a pale optic nerve, which are common clinical features in the diagnosis of retinitis pigmentosa 23.
This test checks side vision and looks for the tunnel vision pattern many people with retinitis pigmentosa can develop. It can help measure how much peripheral vision has been affected over time.
Pictures such as optical coherence tomography and fundus imaging show the retina in detail. These imaging findings can reveal thinning, swelling in the central retina, or areas where light-sensing cells have been lost.
How is Retinitis pigmentosa 23 diagnosed?
Retinitis pigmentosa 23 is usually diagnosed by an eye specialist using a dilated eye exam to look for the typical changes in the retina, the light-sensing layer at the back of the eye, along with tests of side vision and how well the eye responds to light. The doctor will also ask about symptoms such as night blindness and trouble seeing in dim light, and may use photos or scans of the back of the eye to track damage. A genetic test can help confirm that the retinitis pigmentosa is specifically type 23 by finding the gene change linked to it, but it is usually used together with the eye exam and vision tests.
Stages of Retinitis pigmentosa 23
Retinitis pigmentosa 23 does not have defined progression stages. This is because vision changes usually develop gradually over time, and the pattern and speed can differ a lot from one person to another rather than following set step-by-step phases. Doctors usually start with a conversation about early symptoms of retinitis pigmentosa 23, such as trouble seeing in dim light, bumping into things off to the side, or needing more time for your eyes to adjust after entering a dark room. Diagnosis and follow-up often involve an eye exam, visual field testing, retinal imaging, and sometimes genetic testing to help confirm the cause and monitor changes in vision.
Outlook and prognosis
The outlook for retinitis pigmentosa 23 is usually one of slow but progressive vision loss, often beginning with night blindness and loss of peripheral vision and later affecting central vision to a variable degree. Progression can differ substantially even within the same family, so some people retain useful reading or mobility vision well into adulthood while others develop severe visual impairment earlier. Most affected individuals are not at risk of shortened life expectancy from the eye disease itself, and mortality is generally not increased when retinitis pigmentosa 23 occurs on its own. The main long-term burden is visual disability, which can affect independence, driving, work, and safety in low-light settings. Regular follow-up with an eye specialist, low-vision support, and monitoring for treatable complications such as cataract or macular edema can improve day-to-day function even though the underlying retinal degeneration usually continues.
Long-term effects
For many living with retinitis pigmentosa 23, the biggest long-term effect is a gradual change in vision that can affect reading, moving around in dim places, and recognizing faces or objects at a distance. Long-term effects vary widely, but many people notice night vision problems first, followed over time by narrowing side vision and, in some cases, loss of central detail. The pace can differ from one person to another, even within the same family. In medical terms, these are sometimes called late effects or chronic symptoms.
Trouble seeing in low light often remains one of the earliest and most lasting effects. You might notice it first when walking into a dark restaurant, driving at dusk, or moving around the house at night.
Over time, side vision often becomes narrower, sometimes creating tunnel vision. This can make it easier to miss curbs, doorways, or people approaching from the side.
In some people, sharp straight-ahead vision also becomes affected later on. When this happens, reading, seeing facial details, or spotting small objects can become harder.
As vision changes build, everyday tasks may take longer and require more effort. Many people with retinitis pigmentosa 23 find that driving, navigating unfamiliar places, and working in dim settings become difficult or no longer safe.
How is it to live with Retinitis pigmentosa 23?
Living with retinitis pigmentosa 23 often means adjusting to vision that changes slowly over time, usually starting with trouble seeing in dim light and then a gradual narrowing of side vision, which can make moving through crowded places, driving, reading signs, or finding objects more stressful and tiring. Many people with this condition build daily routines around brighter lighting, high-contrast tools, mobility training, and planning ahead, and because this is an inherited eye condition, it can also bring emotional strain for relatives who may help with transportation, home adjustments, or genetic counseling decisions. The pace can vary from one person to another, but with low-vision support, practical accommodations, and a strong support network, many people with retinitis pigmentosa 23 continue to work, study, and stay active in ways that fit their changing vision.
Treatment and drugs
Retinitis pigmentosa 23 is treated mainly by slowing avoidable vision strain, making the most of remaining sight, and checking for problems that can further blur vision, because there is not yet a cure that restores the damaged light-sensing cells. Treatment often looks different for each person, but many living with retinitis pigmentosa 23 are helped by regular eye follow-up, low-vision aids such as magnifiers and screen readers, orientation and mobility training, and practical changes at home for dim light or night blindness. Doctors may also treat related problems like cataracts or swelling in the center of the retina if these develop, since fixing those can sometimes improve day-to-day vision even when the underlying condition remains. Because retinitis pigmentosa 23 is inherited, genetic testing and counseling can help guide eligibility for research studies and, in some cases, gene-based treatment discussions, while your eye specialist can explain what is available now and what may be coming next.
Can you cure Retinitis pigmentosa 23?
No, there is currently no cure for retinitis pigmentosa 23, and treatment cannot restore vision that has already been lost. Care is focused on making the most of the vision that remains, with regular eye checkups, low-vision aids, and support such as mobility training or treatment for related eye problems that can help day-to-day life.
Non-drug treatment
Retinitis pigmentosa 23 can make everyday tasks harder over time, especially moving around in dim light, noticing things off to the side, and reading or working in glare. There is no non-drug therapy that can cure the condition, but several supportive approaches can help protect independence, safety, and quality of life. Supportive therapies can make a real difference at home, at school, at work, and when getting around outdoors. Care is usually tailored to how much vision is affected and how quickly changes are happening.
Low vision rehabilitation helps people with retinitis pigmentosa 23 use their remaining sight more effectively for reading, cooking, shopping, and other daily tasks. This may include magnifiers, better lighting, high-contrast tools, and training in how to position materials to reduce glare.
Orientation and mobility training teaches safer ways to move through hallways, streets, stairs, and unfamiliar places as side vision narrows. For many, treatment begins not at the pharmacy, but with practical skills such as scanning the environment, using landmarks, or learning when a cane may help.
Screen readers, text-to-speech tools, large-print settings, audio labels, and navigation apps can make school, work, and daily planning easier. These tools are often especially helpful once the early symptoms of retinitis pigmentosa 23 begin to interfere with night vision or peripheral awareness.
Changes at home can lower the risk of falls and reduce eye strain during everyday tasks. Brighter task lighting, reduced clutter, high-contrast markings on steps, and control of glare from windows or shiny surfaces can all help.
Your genes may have an impact on how drugs work for you
For people living with retinitis pigmentosa 23, there is no well-established evidence that this genetic change clearly alters how most commonly used everyday medicines work, so treatment choices are not usually based on drug-response genetics. In daily life, this means care is still focused mainly on managing vision changes, using low-vision support, and avoiding medicines known to be harmful to the retina when possible. Genetic testing can still matter, though, because it may help confirm the exact cause of vision loss and show whether someone might qualify for a gene-specific treatment or research study in the future.
Pharmacological treatments
Day to day, treatment for retinitis pigmentosa 23 is mostly about protecting the vision you still have and managing complications that can blur sight further. At this time, there is no approved medicine known to stop or reverse RP23 itself, so drug treatment is usually aimed at problems such as retinal swelling rather than the underlying gene change. Not everyone responds to the same medication in the same way. If you are searching for the best medication for retinitis pigmentosa 23, the answer is often that care is individualized and many people with RP23 may not need drug treatment unless a treatable complication develops.
There is currently no medicine specifically approved to treat the underlying cause of retinitis pigmentosa 23. For many living with RP23, this means regular eye follow-up is often more important than starting a drug.
Acetazolamide tablets and dorzolamide eye drops may be used if RP23 causes cystoid macular edema, a type of retinal swelling that can make central vision blur. These medicines do not cure RP23, but they can help some people read, recognize faces, or see fine detail more clearly.
In some cases, steroid medicines such as triamcinolone or dexamethasone are used when retinal swelling does not improve enough with other options. Because steroids can raise eye pressure or speed cataracts, eye specialists usually weigh benefits and risks carefully.
Medicines such as bevacizumab, ranibizumab, or aflibercept are occasionally considered if there is unusual leaking or swelling in the retina. They are not standard treatment for most people with retinitis pigmentosa 23, but may help selected cases.
Genetic influences
For many, trouble seeing in dim light or a gradual loss of side vision is linked to the gene change behind retinitis pigmentosa 23. This subtype is caused by changes in the OFD1 gene and is inherited in an X-linked pattern, which means the changed gene is on the X chromosome. Family history is one of the strongest clues to a genetic influence, especially when similar vision problems have affected relatives across generations. Because of the way X-linked conditions are passed down, males often have earlier or more severe vision loss, while females who carry the gene change may have milder symptoms or sometimes very subtle findings. Even within the same family, the age when symptoms begin and how quickly vision changes can vary. Genetic testing for retinitis pigmentosa 23 can help confirm the diagnosis, show how it may be passed on, and help relatives decide whether genetic counseling would be useful.
Is Retinitis pigmentosa 23 genetic?
Genetics are central to retinitis pigmentosa 23. It is caused by a change in a specific gene and is usually inherited, so family history and genetic testing can be very important.
Having a genetic risk is not necessarily a diagnosis
Gene variants are a normal part of human biology and are widely found in the general population. Most of these variants do not directly affect health and are simply part of normal human diversity. For many genes, having a variant connected to a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, one well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with retinitis pigmentosa 23, the genetic result behind the condition can shape treatment decisions, even though it usually does not point to one standard medicine that works best. Retinitis pigmentosa 23 is most often linked to changes in the PRPH2 gene, and knowing that can help doctors confirm the diagnosis and see whether gene-specific research studies or future targeted treatments may be a good fit. At present, treatment options for retinitis pigmentosa 23 are still mostly aimed at protecting day-to-day vision and treating complications, such as cataracts or swelling in the center of the retina, rather than using a PRPH2-specific drug. Not every difference in response is genetic, but age, the stage of vision loss, and other eye conditions can all affect how much benefit someone gets from these treatments. For many, genetic testing for retinitis pigmentosa 23 is most useful for guiding follow-up care, family counseling, and access to clinical trials, instead of choosing between common eye medicines.
Interactions with other conditions
For many living with retinitis pigmentosa 23, the main day-to-day issue is gradual trouble seeing in dim light, narrowing side vision, and later more difficulty with detailed central tasks like reading or recognizing faces. Retinitis pigmentosa 23 is usually considered an eye-limited inherited condition rather than a disease that directly causes problems in many other organs, but other eye conditions can still affect how much vision changes over time. Doctors call it a comorbidity when two conditions occur together, and with retinitis pigmentosa 23 this can include cataracts, swelling in the center of the retina, or sometimes glaucoma, all of which may add to blurred or reduced vision. Someone might notice their night vision is getting worse from the retinal disease, then find that glare or hazy daytime vision is also increasing because of a cataract. Because several eye problems can overlap, regular follow-up with an eye specialist is important to sort out the cause of new symptoms and to look for treatable issues alongside retinitis pigmentosa 23.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Retinitis pigmentosa 23?
Retinitis pigmentosa 23 can look similar to other inherited eye conditions that slowly damage the retina, the light-sensing layer at the back of the eye, such as Usher syndrome, choroideremia, and cone-rod dystrophy. More common eye problems, including glaucoma and advanced cataracts, can also cause trouble seeing at night or loss of side vision, so they may be considered at first. Doctors may also check for treatable causes like vitamin A deficiency or, less often, side effects from certain medicines that can affect the retina.
History
People living with retinitis pigmentosa 23 often find that the condition becomes part of family stories long before it is fully explained in a clinic. Someone may remember a parent struggling to see in dim restaurants, or a relative who stopped driving at night years before anyone had a name for it. These everyday patterns helped doctors recognize that some forms of slow, inherited vision loss were linked.
Across cultures and time periods, doctors described people who could see fairly well in daylight but gradually lost night vision and side vision over time. Early medical reports grouped many of these cases under the broader name retinitis pigmentosa, based mainly on what eye doctors could see when examining the retina. Not every early description was complete, yet together they built the foundation of today’s knowledge. As eye exams improved through the 1800s and 1900s, specialists began to understand that retinitis pigmentosa was not one single disorder, but a group of related retinal conditions that can look similar while having different underlying causes.
From these first observations, researchers gradually sorted the different forms by age of onset, pattern of vision loss, and whether other health problems were present. Later, tests of the retina’s electrical activity and detailed retinal imaging helped confirm that the light-sensing cells were being damaged over time, even before major changes were obvious in daily life. For many, this can mean that early symptoms of retinitis pigmentosa 23, such as trouble seeing at dusk or bumping into objects off to the side, were recognized more clearly than in the past.
In more recent decades, genetic research showed that retinitis pigmentosa 23 is one specific form within this larger family of retinal diseases. That shift mattered because it moved care beyond simply describing symptoms and toward understanding why the condition happens in some families. Knowing the condition’s history helps explain why diagnosis may once have been delayed, and why today’s approach is more precise, with clearer testing, counseling, and support for people living with retinitis pigmentosa 23.